SCHEMBL18869166

SCHEMBL18869166

CCO/C(=N\C(=O)c1ccccc1)c1cc(C)cc(C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.43
ALDH1A1 P00352 6/20 0.43
KDM4E B2RXH2 3/20 0.43
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
NPC1 O15118 5/20 0.42
MAPT P10636 4/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
RAB9A P51151 4/20 0.39
HPGD P15428 1/20 0.39
LMNA P02545 1/20 0.39
TPMT P51580 1/20 0.39
TSHR P16473 1/20 0.39
GAA P10253 3/20 0.38
RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22208244 0.89 MEN1 (0.47) SMN1; SMN2ALDH1A1KDM4ENFKB1NFKB2
SCHEMBL22208242 0.89 MEN1 (0.47) SMN1; SMN2ALDH1A1KDM4ENFKB1NFKB2
SCHEMBL18869063 0.86 NPC1 (0.49) SMN1; SMN2ALDH1A1KDM4ENFKB1NFKB2
SCHEMBL17348463 0.82 CYP19A1 (0.46) SMN1; SMN2ALDH1A1KDM4ENFKB1NFKB2
SCHEMBL18869339 0.77 NPC1 (0.44) SMN1; SMN2ALDH1A1KDM4ENFKB1NFKB2
SCHEMBL515715 0.76 MEN1 (0.47) SMN1; SMN2ALDH1A1KDM4ENFKB1NFKB2
SCHEMBL14118714 0.76 MEN1 (0.47) SMN1; SMN2ALDH1A1NPC1MAPTMEN1
SCHEMBL17955731 0.76 MEN1 (0.47) SMN1; SMN2ALDH1A1NPC1MAPTMEN1
SCHEMBL459925 0.76 MEN1 (0.47) SMN1; SMN2ALDH1A1KDM4ENFKB1NFKB2
SCHEMBL9604202 0.76 MEN1 (0.47) SMN1; SMN2ALDH1A1KDM4ENFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3389105-B1 COMPOSITION AND LIGHT-EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL CO (JP) 2021-01-20 EP disclosed
EP-3168223-B1 METAL COMPLEX AND LIGHT EMITTING ELEMENT USING SAME SUMITOMO CHEMICAL CO (JP) 2019-10-16 EP disclosed
US-20170166599-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-06-15 US disclosed
US-20170166599-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-06-15 US disclosed
EP-3168223-A1 METAL COMPLEX AND LIGHT EMITTING ELEMENT USING SAME Sumitomo Chemical Company, Limited (JP) 2017-05-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170166599-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE USING THE SAME CRY1, AP2M1, CCNE2 SMN1; SMN2 3229/4885ALDH1A1 627/4885KDM4E 3950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.